JP2023545076A5 - - Google Patents
Info
- Publication number
- JP2023545076A5 JP2023545076A5 JP2023521459A JP2023521459A JP2023545076A5 JP 2023545076 A5 JP2023545076 A5 JP 2023545076A5 JP 2023521459 A JP2023521459 A JP 2023521459A JP 2023521459 A JP2023521459 A JP 2023521459A JP 2023545076 A5 JP2023545076 A5 JP 2023545076A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- acceptable salt
- compound according
- therapeutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063090150P | 2020-10-09 | 2020-10-09 | |
| US63/090,150 | 2020-10-09 | ||
| PCT/US2021/054135 WO2022076796A1 (en) | 2020-10-09 | 2021-10-08 | Macrocyclic immunomodulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545076A JP2023545076A (ja) | 2023-10-26 |
| JP2023545076A5 true JP2023545076A5 (https=) | 2024-10-16 |
Family
ID=78483564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521459A Pending JP2023545076A (ja) | 2020-10-09 | 2021-10-08 | 免疫調節剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230365628A1 (https=) |
| EP (1) | EP4225774B1 (https=) |
| JP (1) | JP2023545076A (https=) |
| KR (1) | KR20230084211A (https=) |
| CN (1) | CN116323640A (https=) |
| ES (1) | ES2988218T3 (https=) |
| WO (1) | WO2022076796A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024544009A (ja) * | 2021-12-03 | 2024-11-26 | ブリストル－マイヤーズ スクイブ カンパニー | 大員環免疫調節剤 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US5374548A (en) | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| MX9203291A (es) | 1985-06-26 | 1992-08-01 | Liposome Co Inc | Metodo para acoplamiento de liposomas. |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US9308236B2 (en) * | 2013-03-15 | 2016-04-12 | Bristol-Myers Squibb Company | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions |
| CN114929714B (zh) * | 2020-01-06 | 2024-05-31 | 百时美施贵宝公司 | 用于治疗癌症和感染性疾病的作为pd-l1抑制剂和免疫调节剂的大环肽 |
-
2021
- 2021-10-08 KR KR1020237015111A patent/KR20230084211A/ko active Pending
- 2021-10-08 US US18/030,604 patent/US20230365628A1/en active Pending
- 2021-10-08 ES ES21801779T patent/ES2988218T3/es active Active
- 2021-10-08 CN CN202180068355.2A patent/CN116323640A/zh active Pending
- 2021-10-08 EP EP21801779.6A patent/EP4225774B1/en active Active
- 2021-10-08 WO PCT/US2021/054135 patent/WO2022076796A1/en not_active Ceased
- 2021-10-08 JP JP2023521459A patent/JP2023545076A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020515574A5 (https=) | ||
| TR201906470T4 (tr) | İmmünomodülatörler. | |
| JP2023510736A5 (https=) | ||
| JP2023510737A5 (https=) | ||
| JP2016519062A5 (https=) | ||
| JP2023533938A5 (https=) | ||
| JP2024516997A5 (https=) | ||
| JP2020525429A5 (https=) | ||
| JP2019512478A5 (https=) | ||
| JP2021526132A5 (https=) | ||
| JP2018507197A5 (https=) | ||
| JP2016538344A5 (https=) | ||
| JP2017536344A5 (https=) | ||
| JP2020508310A5 (https=) | ||
| JP2018511590A5 (https=) | ||
| JP2016503414A5 (https=) | ||
| HRP20192337T1 (hr) | Makrociklični inhibitori pd-1/pd-l1 i cd80(b7-1)/pd-l1 protein/protein interakcija | |
| JP2013539795A5 (https=) | ||
| JP5852678B2 (ja) | 抗腫瘍剤の効果増強剤 | |
| JP2012153722A5 (https=) | ||
| JP2023500483A5 (https=) | ||
| JP2013522292A5 (https=) | ||
| JP2017515901A5 (https=) | ||
| JP2023517736A5 (https=) | ||
| JP2016526540A5 (https=) |